SOLV
Solventum Corp

582
Mkt Cap
$12.62B
Volume
690,902.00
52W High
$85.92
52W Low
$60.70
PE Ratio
33.52
SOLV Fundamentals
Price
$72.27
Prev Close
$72.76
Open
$72.66
50D MA
$72.66
Beta
0.77
Avg. Volume
1.13M
EPS (Annual)
$2.76
P/B
3.46
Rev/Employee
$375,181.82
Loading...
Loading...
News
all
press releases
SOLV or MEDP: Which Is the Better Value Stock Right Now?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Zacks·1d ago
News Placeholder
More News
News Placeholder
Solventum Appoints Heather Knight as Chief Commercial Officer
Solventum Appoints Heather Knight as Chief Commercial Officer Solventum Appoints Heather Knight as Chief Commercial Officer PR Newswire ST. PAUL, Minn., Oct. 21, 2025 ST. PAUL, Minn., Oct. 21, 2025...
PR Newswire·2d ago
News Placeholder
Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025
Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025 Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025 PR Newswire ST. PAUL, Minn., Oct. 16, 2025 ST...
PR Newswire·7d ago
News Placeholder
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.
Zacks·8d ago
News Placeholder
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
Zacks·10d ago
News Placeholder
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
Zacks·13d ago
News Placeholder
PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell
PACB expands seqWell partnership to enhance its sequencing workflow offerings with a new multiplexing kit.
Zacks·15d ago
News Placeholder
SOLV vs. MEDP: Which Stock Is the Better Value Option?
SOLV vs. MEDP: Which Stock Is the Better Value Option?
Zacks·20d ago
News Placeholder
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·29d ago
News Placeholder
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
Zacks·1mo ago

Latest SOLV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.